Welcome to LookChem.com Sign In|Join Free

CAS

  • or

445305-92-0

cyclobutylmethanesulfonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

445305-92-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 445305-92-0 Structure

  • Basic information

    1. Product Name: cyclobutylmethanesulfonamide
    2. Synonyms: cyclobutylmethanesulfonamide
    3. CAS NO:445305-92-0
    4. Molecular Formula: C5H11NO2S
    5. Molecular Weight: 149.21134
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 445305-92-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 284.1±23.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.277±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 10.86±0.60(Predicted)
    10. CAS DataBase Reference: cyclobutylmethanesulfonamide(CAS DataBase Reference)
    11. NIST Chemistry Reference: cyclobutylmethanesulfonamide(445305-92-0)
    12. EPA Substance Registry System: cyclobutylmethanesulfonamide(445305-92-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 445305-92-0(Hazardous Substances Data)

445305-92-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 445305-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,5,3,0 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 445305-92:
(8*4)+(7*4)+(6*5)+(5*3)+(4*0)+(3*5)+(2*9)+(1*2)=140
140 % 10 = 0
So 445305-92-0 is a valid CAS Registry Number.

445305-92-0Downstream Products

445305-92-0Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

-

, (2009/12/02)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

-

, (2009/12/24)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

-

, (2008/12/04)

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

-

, (2008/12/05)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS

-

, (2008/12/05)

Macrocyclic peptides having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

-

, (2008/12/04)

Macrocyclic peptides are disclosed having the general formula: wherein R3, R′3, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

-

Page/Page column 31, (2008/12/04)

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 63, (2008/12/05)

Macrocyclic peptides having the general formula (I): are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

-

Page/Page column 32-33, (2008/06/13)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors

-

Page/Page column 34, (2008/06/13)

The present disclosure relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 445305-92-0